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In Brief
Molecular mechanisms regulating specific synaptic GABA A R accumulation are critical for the fidelity of inhibitory neurotransmission. Nathanson et al. show that strengthening the interaction between a1-GABA A Rs and collybistin via genetic manipulation results in augmented synaptic targeting of these receptors, enhanced inhibitory neurotransmission, and seizure resilience.
INTRODUCTION
Brain function in the mammalian nervous system depends on a dynamic relationship between excitatory and inhibitory neurotransmission (Fritschy, 2008; Selten et al., 2018) . Inhibitory interneurons precisely control the firing of excitatory pyramidal neurons and thus regulate network activity patterns (Roux and Buzsá ki, 2015) . Interneurons inhibit the activity of pyramidal cells by releasing the neurotransmitter g-aminobutyric acid (GABA) onto synapses containing GABA type A receptors (GABA A Rs). GABA A Rs are heteropentameric, ligand-gated ion channels permeable to chloride. GABA A Rs can be composed from 19 different subunits, but synaptic GABA A Rs are understood to be primarily assembled from 2 a(1-3), 2 b(1-3), and 1 g2 subunits (Olsen and Sieghart, 2008; Sigel and Steinmann, 2012) . Although the structure of these subunits is highly conserved, the specific combination of subunits in a given GABA A R does confer distinct physiological and pharmacological properties on the receptor (Goldstein et al., 2002; Rudolph et al., 1999) . Subunit types are also differentially localized within the neuron. For example, GABA A Rs containing the a1 subunit tend to be found in dendritic synapses, while those containing a2 are highly enriched in axoaxonic synapses at the axon initial segment (AIS) (Klausberger et al., 2002; Nusser et al. 1996; Nyíri et al. 2001) , the site of action potential (AP) initiation (Kole and Stuart, 2012) . Recently, it has been shown that disturbing this subunit distribution in a mouse model (Gabra2-1) can disrupt inhibitory control of excitation and lead to seizures and early mortality (Hines et al., 2018) .
Clearly, then, pyramidal neurons must precisely control the allocation of GABA A R subtypes to specific subcellular sites. The exact mechanisms by which this distribution is attained, however, remain unclear. Previous work suggests that interactions between the a subunit and intracellular proteins may be a determinant of GABA A R localization (Mukherjee et al., 2011; Tretter et al., 2008; Tretter and Moss, 2008) . Although the sequences of a subunits are largely homologous, there is a significant area of divergence in the intracellular domain (ICD) that lies between transmembrane domains 3 and 4 (Olsen and Tobin, 1990) . A 15-amino acid sequence within the ICD of a2 has been shown in vitro to mediate preferential binding to the inhibitory synaptic protein collybistin (CB). Replacing this a2-specific motif with the analogous sequence of a1 causes loss of a2-containing synapses at the AIS, suggesting that CB may play a role in the formation of subtype-specific inhibitory synapses via its interaction with a2 (Hines et al., 2018) .
CB is a guanine nucleotide exchange factor that activates the small GTPase Cdc42, a regulator of the actin cytoskeleton. There are a number of CB isoforms, but the protein is generally composed of 3 domains: the pleckstrin homology (PH) phosphoinositide-binding domain, the catalytic RhoGEF (DH) domain, and the N-terminal Src-homology 3 (SH3) domain (Harvey et al., 2004; Xiang et al., 2006) . CB was first identified as a gephyrin-interacting protein (Kins et al., 2000) . Gephyrin (GPN) is an integral component of the inhibitory synapse that is known to bind directly to a subunits of GABA A Rs, forming a submembrane scaffold that anchors the receptors at the synapse (Mukherjee et al., 2011; Tretter et al., 2008 Tretter et al., , 2012 . CB binds GPN via the DH domain and facilitates the aggregation and stabilization of GPN in the submembrane space (Grosskreutz et al., 2001; Kins et al., 2000; Tyagarajan et al., 2011) . CB-knockout mice display a loss of both GPN and GABA A Rs at postsynaptic structures in the hippocampus (Papadopoulos et al., 2008 (Papadopoulos et al., , 2007 , and mutations in the human CB gene ARHGEF9 are associated with epileptic diseases (Kalscheuer et al., 2009; Papadopoulos et al., 2015; Shimojima et al., 2011) . CB, therefore, is an attractive candidate for the regulation of subtype-specific synapse formation, via preferential interactions with the ICD of a2. However, no study has examined the association between CB and the a2 ICD motif in brain tissue or fully (B) Representative western blots examining expression of key components of the inhibitory synapse in total hippocampal lysates. GAPDH served as a loading control. (C) Pooled quantification (n = 5 biological and technical replicates) reveals that the Gabra1-2 mutation leads to a decrease in the total expression of the a1 subunit, a trending decline in total a2 subunit expression (p = 0.077), and an increase in total CB expression. (D) Representative western blots from biotinylated hippocampal slices examining the surface expression of the a1 and a2 subunits. Total a1/2 subunit was normalized to GAPDH. Surface a1/2 subunit was normalized to pan-cadherin. (E) Pooled quantification (n = 5 biological and technical replicates) shows no change in the surface:total ratio of the a1 subunit in Gabra1-2 mutants but reveals a significant decrease in the surface expression of the a2 subunit. Unpaired t tests with Welch's correction used for statistical analysis. (*p < 0.05; **p < 0.01). All data are expressed as the percentage of WT and error bars represent mean ± SEM. assessed the effect that this association has on the trafficking and stabilization of a1-and a2-containing GABA A Rs at synapses. To this end, we developed a knockin mouse in which the CB binding motif in the a2 loop is substituted into a1 (the Gabra1-2 mouse). We observed that this mutation does indeed enhance the association of the a1 subunit with CB in brain lysate. The mutation also alters the expression of a1, causes the enrichment of a1-GABA A Rs at the AIS, and increases the size and density of a1-containing synapses in cultured hippocampal cells. In addition, the Gabra1-2 mutation alters both phasic inhibition in the CA1 and baseline cortical electroencephalographic (EEG) activity, resulting in resistance to kainate-induced seizures. To demonstrate the strength of the seizure-resistant phenotype, we crossed Gabra1-2 mice with Gabra2-1 seizure-prone mice and found that the double heterozygous animals are spared from the lethality observed in Gabra2-1 mutants.
RESULTS
The Creation of the Gabra1-2 Mutant Mouse To probe the interaction between CB and the a2 ICD-binding motif and determine its importance in synapse formation, we generated a knockin mouse in which amino acids 360-375 of the a1 ICD were replaced by those of the a2 subunit (Figure 1A ; Figure S1A ). Mice were generated using homologous recombination in ES cells (Genoway), as outlined previously (Moore et al., 2018; Terunuma et al., 2014; Vien et al., 2015) . To confirm the Gabra1-2 mutation, we amplified the relevant portion of genomic DNA from wild-type (WT) and homozygous Gabra1-2 mice and sequenced the resulting PCR product, confirming the insertion of the a2 amino acid sequence into a1 ( Figure S1B ). Mice were genotyped by PCR using primers that detected the a2 insertion ( Figure S1C ). Gabra1-2 homozygotes were viable and did not display any overt phenotypes. Motor behavior, as measured by latency to fall off a rotarod beam and the total distance traveled in the open field test, was unaffected ( Figure S2 ). In addition, cresyl violet staining showed no differences in gross hippocampal anatomy between WT and mutant animals ( Figure S1D ).
Changes in GABA A R Trafficking and Surface Stability in the Gabra1-2 Mouse Next, we investigated the effect the Gabra1-2 mutation has on the expression and trafficking of inhibitory synapse components. To this end, we immunoblotted total hippocampal lysates for the a1 and a2 subunits, GPN, CB, and synapsin ( Figure 1B) , as well as the b3 and g2 subunits ( Figure S1E ). There were no changes in the total expression of any of these proteins in heterozygous Gabra1-2 mice compared with WT (data not shown). In homozygous animals, total levels of synapsin were unchanged, indicating no widespread changes in synapse formation ( Figure 1C ). We found that the total CB was increased in homozygous mutants compared with controls, while GPN was unchanged ( Figure 1C ). We found no changes in either b3 or g2 expression in homozygous animals compared to WT ( Figure S1E ). Immunoblotting showed that the total a1 expression decreased in homozygous Gabra1-2 mutants compared to controls, and total expression of a2 also trended toward a decrease ( Figure 1C ). To examine these findings in more depth, we performed surface biotinylation experiments in WT and Gabra1-2 homozygous hippocampal slices ( Figure 1D ). To better detect the low levels of surface a2 subunit, these experiments were performed using the previously described pHlourin-a2 mice (Nakamura et al., 2016) -in which the a2 subunit is GFP-tagged-crossed with Gabra1-2 animals. We found that the ratio of surface to total protein for a1 was unchanged, while that for the a2 subunit was reduced in mutants compared with controls ( Figure 1E ), consistent with the decline in total a2 expression ( Figure 1C ). Collectively, these results indicate a change in the trafficking of a subunits in Gabra1-2 mutants: a2-containing GABA A Rs are displaced by a1-containing receptors accumulating in the plasma membrane. The data indicating a depression in total a1 and a2 expression ( Figure 1C ) was obtained from crude hippocampal lysates, which contain the large intracellular pool of a subunits. Thus, the reduction in the total expression of a subunits may reflect a compensatory reduction in the intracellular pool in response to additional plasma membrane accumulation of a1-GABA A Rs.
The Gabra1-2 Mutation Enhances the Interaction between a1 and CB It has been established that the a2 ICD motif mediates a preferential interaction with CB over GPN in vitro (Hines et al., 2018) . To confirm this finding in vivo, we performed co-immunoprecipitation (coIP) experiments on forebrain plasma membrane lysates from WT and Gabra1-2 mice. Lysates were incubated with magnetic beads cross-linked to an N-terminal a1 antibody. Bound material was eluted from the beads and subjected to SDS-PAGE, followed by immunoblotting for either a1, CB, or GPN. a1 immunoblots showed excellent purification of the subunit from the total lysate and revealed reduced a1 in homozygotes, in both the input and the immunoprecipitate (IP), consistent with our earlier results ( Figure 1C ). Total and immunoprecipitated CB levels, particularly the high molecular weight isoforms, were increased in the Gabra1-2 IP compared with WT, confirming that the a2 ICD motif does indeed mediate a preferential association with CB in vivo (Figure 2) . Interestingly, GPN levels were also increased in the mutant IP compared with WT, indicating an enhanced interaction between GPN and the mutant a1 subunit ( Figure 2 ). As it has been previously shown that GPN can bind both a subunit ICDs and CB (Grosskreutz et al., 2001; Mukherjee et al., 2011; Tyagarajan et al., 2011) , these data suggest that, via binding at the a2 ICD motif, GABA A Rs, CB, and GPN form a synergistic tripartite complex in which strengthening the interaction between two partners enhances the stability of the entire complex.
The Gabra1-2 Mutation Is Sufficient to Target a1-Containing GABA A Rs to the AIS Our previous work has demonstrated that the a2 ICD motif is necessary for the accumulation of GABA A Rs at the AIS (Hines et al., 2018) . To determine if this motif is sufficient for the formation of these precisely localized synapses, we performed immunocytochemistry (ICC) on WT and Gabra1-2 homozygous DIV21 hippocampal neurons. ICC was selected to allow for superior resolution of subcellular compartments, including the AIS. Neurons (B) Pooled quantification (n = 4 biological and technical replicates) of protein immunoprecipitation shows a significant reduction in the pull-down of the a1 subunit and significant increases in the pull-down of CB and GPN with the chimeric a1-2 subunit. Total protein expression data were normalized to GAPDH, and IP expression data were normalized to total a1 due to the decrease in total a1 expression in Gabra1-2 mutants. Unpaired t tests with Welch's correction were used to analyze data (*p < 0.01; **p < 0.05; #p < 0.005). Data are expressed as the percentage of WT and error bars represent mean ± SEM.
were co-labeled with antibodies against AIS markers (pan-Na + and ankyrin G, together) and either the GABA A R a1 or a2 subunit. Imaging revealed a striking phenotype: chimeric a1-containing GABA A Rs formed significantly denser and larger puncta on Gabra1-2 AIS segments, compared with WT AIS segments (Figures 3A-3B ). In addition, the number and size of synapses positive for the a1 subunit was far larger in the somatodendritic compartments of mutant neurons ( Figures 3A-3B ). Experiments examining the localization of a2-containing GABA A Rs showed neither changes in the levels of a2 at the mutant AIS nor alterations in the density or size of a2 positive synaptic puncta ( Figures 3C-3D ). These results indicate that the a2 360-375 motif does not simply allow GABA A Rs to access and remain at the AIS, but it also stabilizes receptors at synapses versus the extrasynaptic space in the soma and dendrites, providing a mechanism for the previously observed greater synaptic clustering of the a2 subunit (Tretter et al., 2008) . This interpretation is strengthened by data from a co-localization analysis performed on whole neurons showing that the co-localization of a1 puncta and the vesicular GABA transporter (VGAT, presynaptic marker), as measured by the Pearson's correlation coefficient, was significantly increased in Gabra1-2 neurons ( Figures S3A-S3B ). In addition, the co-localization of a1 puncta and GPN puncta was significantly increased in mutant neurons ( Figures S3C-S3D ). In contrast, the Gabra1-2 mutation does not affect the co-localization of a2 and VGAT ( Figures S4A-S4B ).
To ensure that there were no gross changes in inhibitory synapse formation, neurons were co-labeled for AIS markers, GPN, and VGAT. Co-localization between GPN and VGAT puncta was unchanged by the Gabra1-2 mutation ( Figures S4C-S4D ). Further analysis revealed a significant increase in the density and size of VGAT puncta specifically in the soma and dendrites of Gabra1-2 neurons, with VGAT distribution at the AIS unchanged ( Figure S5 ). Analysis of GPN puncta showed the opposing effect: GPN puncta at the AIS were significantly smaller and more numerous in Gabra1-2 neurons when compared with WT controls, with no changes in the soma and dendrites ( Figure S6 ). These results indicate that, in response to the increase in a1 positive synapses on pyramidal neurons, only inhibitory interneurons contacting the soma and dendrites create more presynaptic terminals. The change in AIS GPN from the one or two large cartridges seen in WT ( Figure S6A ) neurons to small, numerous puncta in mutants suggests that increased stabilization of the chimeric a1-GABA A Rs at the AIS requires a reconfiguration of the postsynaptic structure. To investigate this phenomenon further, neurons were labeled with antibodies against AIS markers and CB. Unfortunately, CB staining produced a diffuse stain throughout Cell Reports 28, 670-681, July 16, 2019 673 (B and C) Quantification of mIPSC kinetics (n = 6 mice/genotype in 3 cohorts) shows no effect of the mutation on mIPSC frequency (B), but (C) reveals a significant decrease in the mIPSC decay time.
(D) Analysis of tonic inhibition in the CA1 (n = 8 mice/genotype in 4 cohorts) showed no difference between WT and homozygous animals. In-depth analysis of CA1 pyramidal neuron mIPSC amplitudes from WT and Gabra1-2 hippocampal slices (n = 6 mice/genotype in 3 cohorts) revealed a shift toward more high amplitude events in Gabra1-2 mutants.
(legend continued on next page) the neuron, impeding analysis of any changes in the subcellular distribution of CB ( Figure S7 ).
Faster Mini Inhibitory Postsynaptic Current (mIPSC) Decay Times and a Shift in mIPSC Amplitude
Distribution in Gabra1-2 Neurons Our biochemical and immunostaining experiments revealed changes in the expression and clustering of mutant a1-containing GABA A Rs, creating larger and denser inhibitory synapses. To assess any effects these alterations could have on inhibitory synaptic signaling, we examined the kinetics of mIPSCs in CA1 pyramidal neurons ( Figure 4A ). The frequency of mIPSCs was unaffected by the Gabra1-2 mutation ( Figure 4B ). mIPSC decay times were significantly decreased in mutant neurons compared with WTs ( Figure 4C ). Examination of tonic inhibition in the CA1 showed no changes between WT and homozygous mice (Figure 4D) . While the average mIPSC amplitude was unchanged (data not shown), further analysis showed that the Gabra1-2 mutation increased the proportion of high amplitude events . Fitting the data to Gaussian curves showed that the mIPSC amplitude distribution in WT mice was best described by the sum of 3 Gaussian components ( Figure 4G ); in Gabra1-2 mice, however, the mIPSC amplitude distribution was best described as the sum of 4 Gaussian components, with the first three similar in amplitude to the WT components and the fourth consisting of a high amplitude component exclusive to Gabra1-2 mutants ( Figure 4H ). These data demonstrate that enhancing the size and density of inhibitory synapses promotes inhibitory neurotransmission.
(E and F) The relative (E) and cumulative (F) frequency of mIPSC events of different amplitudes. (G and H) Fitting the data to Gaussian curves and creating mIPSC histograms for WT (G) and Gabra1-2 (H) demonstrates the existence of a fourth, higher amplitude (Peak 4, blue, mean = À80.7 pA) curve in mutants that does not exist in WT. This result indicates that a population of high amplitude mIPSCs occurs exclusively in Gabra1-2 hippocampal slices. Mann-Whitney tests were used to analyze mIPSC kinetics and tonic current data (#p < 0.05) and error bars represent mean ± SEM for these experiments. For (G) and (H), data are expressed as mean ± SEM amplitudes (pA) for each of the Gaussian components used to obtain optimal fits to the data. Alterations in Baseline EEG Activity in Gabra1-2 Mice Gabra1-2 mice experience changes in the distribution of subtype-specific GABA A Rs and presynaptic inputs, as well as enhanced inhibitory neurotransmission. Given that inhibitory control of pyramidal neurons is known to play an important role in the generation of cortical oscillations measured by EEG (Buzsá ki and Chrobak, 1995; Mann et al., 2005; Roux and Buzsá ki, 2015) , we assessed baseline cortical EEG activity in WT and Gabra1-2 mice. Mice were recorded for at least 1 hour of wakefulness one week following EEG/electromyogram (EMG) implantation. Representative spectrograms and fast-Fourier transformation of 10 minutes of this awake EEG activity showed changes in specific frequency bands between WT and Gabra1-2 littermate controls ( Figures  5A-5B ). To examine these changes in more depth, we parsed the EEG activity into the following frequency bands: d (1-4 Hz), q (4-8 Hz), a (8-13 Hz), b (13-30 Hz), low g (30-50 Hz), and high g (50-100 Hz). Comparison of the relative power of each of these bands between WT and Gabra1-2 animals revealed a significant elevation in the a range in mutants compared with WT ( Figure 5C ).
Resistance to Kainate-Induced Seizures in Gabra1-2 Mice Electrophysiological experiments show that inhibitory neurotransmission is changed in Gabra1-2 mice. To determine if these physiological changes affect seizure susceptibility, known to be at least partially dependent on inhibitory control of excitation (Fritschy, 2008) , we employed the kainate model. Kainate (KA, 20 mg/kg, i.p.) was administered to WT and homozygous adult male littermates that were previously implanted with cortical EEG and EMG monitors. Using the EEG and EMG data to determine the onset of epileptic activity and status epilepticus (SE) ( Figures 6A-C) , we found that homozygous animals experienced (legend continued on next page) their first tonic-clonic seizure later than WT littermate controls ( Figure 6D ). In addition, the latency to entering SE was longer in homozygous mice ( Figure 6E ). Mutant animals also exhibited resilience to SE-induced mortality: no homozygous animals died in the two hours following KA injection, while about 40% of WTs died during SE ( Figure 6F ). To explore the nature of epileptic activity in Gabra1-2 animals further, we performed fast-Fourier transformation on EEG recordings of SE and parsed the recordings into the specific frequency bands outlined above. This analysis revealed that Gabra1-2 mice experienced a specific reduction in the relative power of the high g band (50-100 Hz) during SE ( Figures 6G-6H) . Collectively, these data show that the molecular and physiological changes induced by the Gabra1-2 mutation provide resilience to KA-induced seizures by blunting high g power.
The Gabra1-2 Mutation Rescues Early Mortality in Gabra2-1 Mice Gabra2-1 mice possess a chimeric a2 subunit in which residues 360-375 from the a1 subunit have been knocked in to replace the normal a2 ICD motif. This mutation leads to a loss of inhibitory synapses at the AIS. Both heterozygous and homozygous Gabra2-1 pups display early mortality, with death peaking at postnatal day 20 (PND20) due to spontaneous seizure activity (Hines et al., 2018) . To determine if the Gabra1-2 mutation rescues the Gabra2-1 mortality phenotype, homozygous Gabra1-2 mice were crossed with homozygous Gabra2-1 mice. The resulting offspring were genotyped by PCR with primers that detected both the a1 and a2 insertions and were confirmed to be heterozygous for both mutations ( Figure 7A ). Gabra2-1 heterozygous pups and Gabra1-2/Gabra2-1 double heterozygous pups were monitored each day after birth until PND40. Of the double heterozygous pups, 100% survived to PND40 compared with only 61% of the Gabra2-1 heterozygous animals ( Figure 7B ), demonstrating that the Gabra1-2 mutation and subsequent phenotype can rescue early mortality in Gabra2-1 animals, likely by promoting the synaptic localization of chimeric a1-GABA A Rs.
DISCUSSION
We have provided evidence that the a2 360-375 ICD motif mediates a preferential interaction with CB in vivo and that the presence of this motif in a given GABA A R is sufficient to stabilize that receptor at the AIS. In addition, the a2 motif may constitute an ''inhibitory synaptic targeting'' signal, generally enhancing the anchoring of GABA A Rs in the synaptic space, as the Gabra1-2 mutation caused the accumulation of chimeric a1-GABA A Rs at somatodendritic synapses, altering inhibitory neurotransmission and baseline network oscillations. These changes were sufficient to ameliorate the severity of kainate-induced seizure activity. The Gabra1-2 mutation was also sufficient to rescue the lethal seizure phenotype previously described in Gabra2-1 mice (Hines et al., 2018) .
Unexpectedly, given that recent in vitro data showed a relatively low affinity between GPN and the a2 ICD motif (Hines et al., 2018) , the Gabra1-2 mutation also led to an enhanced in vivo interaction between the chimeric a1 subunit and GPN. Previous work in Y2H systems has suggested that GPN, CB, and the a2 subunit form a trimeric complex; interactions between GPN/a2 and CB/a2 were potentiated in the presence of CB and GPN, respectively (Saiepour et al., 2010) . In addition, a2-GABA A Rs are more clustered at synapses than those containing a1, a phenomenon at least partially dependent on the presence of GPN (Tretter et al., 2008) . Our results support the notion of a ''tripartite complex'' composed of GPN, CB, and an a2 subunit, in which strengthening the interaction between two of the complex's partners stabilizes the entire trimer. GABA A Rs are known to be initially inserted into the plasma membrane extrasynaptically (Bogdanov et al., 2006; Thomas et al., 2005) ; they then laterally diffuse via Brownian motion until they contact scaffolding proteins in the synaptic space. These scaffolding proteins, including GPN (Jacob et al., 2005) , contact the receptors, slowing their diffusion rate and immobilizing receptors at the synapse (Choquet and Triller, 2013; Renner et al., 2008; Choquet, 2005, 2008) . Previous work has shown that the g2 subunit is necessary for the synaptic anchoring process (Alldred et al., 2005) ; however, the g2 subunit is promiscuous and is an unlikely candidate for GABA A R subtype-specific synaptic targeting. We demonstrate that a GPN-CB complex could act as a subtype-selective structural anchor at the synapse, specifically interacting with only those a subunits containing the a2 ICD motif, creating a super-stable trimer that anchors the GABA A R component at the synapse. The increased synaptic clustering of mutant a1-GABA A Rs seen in the Gabra1-2 mouse is likely due to increased recruitment of these receptors from the extrasynaptic space to the synapse via the a2 motif-CB-GPN interaction. In the AIS, where a2 is particularly enriched, the presence of the trimeric complex would be especially important for the stabilization of a2-GABA A Rs. a1-GABA A Rs may be able to access the AIS but will not stabilize as effectively at axo-axonic synapses due to a1's weaker interaction with CB. Other proteins that are essential in AIS structure-including Ankyrin G and bIV-spectrin (Susuki and Rasband, 2008) investigate potential interactions between the a2 subunit and these AIS components and test the necessity of such interactions to the presence of GABA A Rs at the AIS.
In the chimeric Gabra1-2 mouse, a1-GABA A Rs containing the a2 ICD motif acquire an ''a2-like'' pattern of distribution, with greater synaptic clustering resulting in the proliferation of inhibitory synapses. Affected neurons undergo some compensation in response to these changes: reducing total levels of a1 subunit expression, increasing CB expression, and displacing surface a2-GABA A Rs. Still, our data demonstrate that the Gabra1-2 mutation enhances inhibitory neurotransmission. Larger proportions of high-amplitude mIPSCs are a result of the significant increase in large, stable inhibitory synapses in Gabra1-2 neurons, while changes in decay kinetics likely reflect an alteration in the type of GABA A Rs on the surface. Different a subunit compositions have been previously shown to affect mIPSC decay time (Goldstein et al., 2002) ; an increase in the proportion of a1-GABA A Rs at the synapse could shift the type of decay seen in mIPSC recordings.
Interestingly, our data demonstrate that the alterations in inhibitory neurotransmission caused by the Gabra1-2 mutation perturb network activity and result in abnormal EEG activity at baseline. Specifically, Gabra1-2 mice show an increase in the power of the a band. Inhibitory interneurons are thought to shape neuronal oscillations (Klausberger and Somogyi, 2008) , including the a band (Lozano-Soldevilla, et al., 2014) , and it is likely that the constitutive Gabra1-2 mutation also affects interneurons themselves, as shown by the observed increase in VGAT positive presynaptic contacts onto mutant pyramidal neurons. The Gabra1-2 mutation may also affect the interplay between interneurons and pyramidal neurons within neuronal networks. Either of these two putative effects could cause changes in network synchrony. Future research into the specific effect of the Gabra1-2 mutation on interneurons, particularly experiments examining changes in the types of interneurons contacting pyramidal cells, would elucidate the mechanisms at play. Furthermore, in both humans and mice the a frequency band is associated with behavioral inhibition, a process that underlies a variety of cognitive tasks, including attention and working memory (Knyazev, 2007) . In addition, benzodiazepine sedation induces a decrease in a band power (Hotz et al., 2000) . Future research should examine the possibility that Gabra1-2 mice may be resistant to the sedative effects of these GABAergic pharmacological agents and may also perform better at tasks measuring behavioral inhibition, such as the Go/No-Go task (Gubner et al., 2010) .
While the mechanisms of ictogenesis remain unclear, it is generally accepted that inhibitory control of excitation is a contributing factor (Fritschy, 2008) . In addition, AIS dysfunction and mutations in the human CB gene ARHGEF9 are both linked to epileptic disorders in humans (Buffington and Rasband, 2011; de Groot et al., 2017; Kalscheuer et al., 2009; Shimojima et al., 2011; Wimmer et al., 2010) . The Gabra1-2 mutation enhances inhibitory neurotransmission, resulting in a reduction in the susceptibility of Gabra1-2 mice to kainate-induced seizures. Intriguingly, neuronal activity during SE seems to be altered: the Gabra1-2 mutation blunts the increase in g band power commonly seen during SE (Sharma et al., 2018) . Inhibitory interneurons are thought to shape neuronal oscillations, including the g band (Mann et al., 2005; Wang et al., 2016) , via synchronization of large pyramidal cell networks (Klausberger and Somogyi, 2008) and have been found to undergo morphological and functional changes in animal models of epilepsy (Smith, 2014) . The Gabra1-2 mutation may prevent or compensate for KA-induced aberrant interneuron activity, thus mitigating pathological neuronal synchronization, ameliorating SE severity, and promoting survival. Interestingly, other genetic manipulations that affect GABAergic transmission have been shown to blunt g power and SE severity in the same way as the Gabra1-2 mutation (Moore et al., 2018) , suggesting a possible common pathway to reducing SE severity and mortality. (A) Genotyping for a Gabra1-2 homozygous (+/+) positive control, a Gabra2-1 homozygous (+/+) positive control, and two Gabra1-2/Gabra2-1 double heterozygous (+/À) animals. Primers to detect the a1-2 and the a2-1 mutation were used on both double heterozygotes. (B) The Gabra1-2 mutation rescues the lethal seizure phenotype that leads to early mortality in Gabra2-1 heterozygotes. Data are shown as a percentage of Gabra2-1 and double heterozygous animals alive at a given time after birth (n = 20 mice/genotype).
In the previously described Gabra2-1 mouse model, the ICD motif of the a2 subunit is replaced with that of a1. Consistent with the proposed importance of the a2 ICD motif in the stabilization of GABA A Rs at the AIS and elsewhere, Gabra2-1 animals lose both the majority of inhibitory synapses at the AIS and inhibitory synapses that oppose parvalbumin positive inputs in the somatodendritic compartments. Gabra2-1 mice, both heterozygous and homozygous, experience spontaneous seizures in the postnatal period, often leading to early mortality around PND20 (Hines et al., 2018) . Given that the Gabra1-2 mutation seems to lead to the opposite effects of the Gabra2-1 mutation, it is perhaps unsurprising that crossing these two strains results in a rescue of the early mortality phenotype of Gabra2-1 animals. The restoration of inhibitory synapses at the AIS and the increase in size and density of a1-containing synapses due to the Gabra1-2 mutation likely compensates for the loss of a2-mediated inhibitory neurotransmission in Gabra2-1 mice. Importantly, the Gabra2-1 mutation reproduces the effects of many epileptogenic ARHGEF9 mutations in humans (Hines et al., 2018) ; the rescue of Gabra2-1 by Gabra1-2 suggests that manipulating the distribution of a1-GABA A Rs or targeting the CB-GPN-a2 complex could represent new avenues for research into therapies for ARHGEF9-associated disorders.
Taken together, we report evidence of a preferential interaction in vivo between CB and the a2 ICD motif and show that this interaction is sufficient to stabilize GABA A Rs at the AIS. Our data support the theory of a trimeric CB-GPN-a2 subunit complex at inhibitory synapse and present a possible explanation for the higher synaptic clustering of a2-GABA A Rs over a1-GABA A Rs. These insights improve our understanding of the subtype-specific inhibitory synaptogenesis that is so important for normal brain function. Finally, Gabra1-2 mice are resilient to kainate-induced seizures and rescue the ictogenic effects of the Gabra2-1 mutation, revealing a new avenue of investigation into treatments of epileptic disorders.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Stephen J. Moss (Stephen.moss@tufts.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal Studies Animals were cared for in accordance with the NIH Guide for the Care and Use of Laboratory Animals, and all protocols were approved by the Institutional Animal Care and Use Committee (IACUC) of Tufts University School of Medicine. Gabra1-2 animals were generated by Genoway (Lyon, France) and maintained in the vivarium at Tufts University's Boston campus on a 12-hour light/dark cycle with constant temperature and humidity. All animals except those that underwent EEG/EMG surgery were grouphoused and had access to food and water ad libitum, with once weekly cage changes. Germline transmission of the transgene was detected using PCR with primers spanning the intronic region containing the remaining LoxP site. After founder Gabra1-2 mice were received from Genoway, mice were backcrossed onto the C57Bl6J line for at least 10 generations prior to experiments. For all experiments, nontransgenic (wild-type, WT) littermates were used as controls. a2 surface expression experiments involved the generation of a Gabra1-2/Myc-pHlourin-a2 (pHa2) double homozygote line. Gabra1-2 homozygotes and preexisting pHa2 homozygotes were bred for several generations until double homozygotes were born. In pHa2 animals, a pHlourin and Myc tag is incorporated into the N-terminal of the mature a2 subunit protein (Nakamura et al., 2016) , allowing for better detection of low levels of a2 expression. In experiments involving the double homozygotes, WT/pHa2 littermates were used as controls. Rescue and survival experiments involved the generation of Gabra1-2/Gabra2-1 heterozygotes, which was achieved by breeding Gabra1-2 homozygotes and preexisting Gabra2-1 homozygotes (Hines et al., 2018) together. All experiments save cell culture immunocytochemistry (ICC) and co-immunoprecipitation employed only male mice, aged 8-12 weeks. Co-immunoprecipitation experiments used age-and sex-matched 8-12-week old male and female mice.
Cell Culture Primary cultures of hippocampal neurons for ICC were prepared from monogenotype WT and homozygous Gabra1-2 litters. Hippocampi from anaesthetized WT and Gabra1-2 P0 male and female neonates were dissected in ice-cold Hank's buffered salt solution (HBSS, ThermoFisher, #14185052) with 10 mM HEPES and subsequently pooled and incubated with 0.1% (v/v) trypsin (ThermoFisher, #15090046) in HBSS for 20 minutes at 37 C. Cells were then washed one time with HBSS and triturated in fresh media to dissociate neurons. After filtering with a 40 mm nylon mesh strainer (ThermoFisher, #22363547) to remove non-dissociated tissue, resulting hippocampal neurons were counted on a hemocytometer and plated on poly-L-lysine (1 mg/mL, Sigma, #P1274)-and laminin (1mg/mL, Sigma, #L2020)-coated glass coverslips in 35 mm dishes with 3 mL of Neurobasal-A culture medium (ThermoFisher, #10888022) containing 2% B27 (v/v; ThermoFisher, #17504044), 1% penicillin/streptomycin (v/v; ThermoFisher, #15140122), 0.6% D-glucose (w/v; Sigma, #G8270), and 1% GlutaMAX (v/v; ThermoFisher, #35050061) at a density of 5 3 10 5 cells/dish. Cells were grown at 37 C, 5% CO 2 and 95% humidity, and allowed to mature for 21 days (Day in vitro 21, DIV21).
METHOD DETAILS
Cresyl violet staining 8-12-week-old male WT and Gabra1-2 mice were transcardially perfused with 30 mL of phosphate buffered saline (PBS, pH 7.4), followed by 60 mL of 4% (v/v) paraformaldehyde in 0.15 M sodium phosphate buffer (PFA). Brains were post-fixed in PFA for 3 hours, then washed in PBS and transferred to 30% sucrose solution for cryoprotection. Brains were embedded in optimal cutting temperature compound (ThermoFisher, #23730571) and frozen at À80 C. Brains were subsequently sliced on a cryostat (ThermoFisher, #HM 525) into 40 mm sections and mounted onto gelatin-coated glass slides (Southern Biotech, #SLD01-CS). Mounted sections were sequentially washed for 1 minute in (all v/v) 75% ethanol, 95% ethanol, 100% ethanol, distilled water, and then incubated in filtered cresyl violet solution for 10 minutes (0.3% glacial acetic acid v/v, 0.5% cresyl violet acetate w/v). Staining was followed by 1-minute sequential washes in distilled water, 75% ethanol, 95% ethanol, 100% ethanol, and xylene. Images were acquired using a Nikon E800 microscope (Nikon) with a 4x objective. 3 animals per genotype were imaged.
Western blotting 8-12-week-old male WT and Gabra1-2 mice were anaesthetized with isofluorane and their brains were rapidly removed. Whole hippocampi were dissected out and mechanically homogenized with a 26G needle in ice-cold lysis buffer containing 5 mM EDTA, 5 mM EGTA, 1 mM sodium orthovanadate, 100 mM NaCl, 10 mM NaH 2 PO 4 , 25 mM NaF, 2% Triton-X (v/v), and protease (mini cOmplete, Roche, #11836153001) and phosphatase inhibitor cocktails (PhosStop, Roche, #4906845001). Tissue was allowed to lyse on a rotator for 30 minutes at 4 C. Samples were then centrifuged at 13,000rmp for 15 minutes at 4 C to pellet insoluble material. Following lysis, protein concentration of the supernatant was assessed with a bicinchoninic acid (BCA) assay (Pierce, #23225) and samples (50 mg) were boiled for 10 minutes at 70 C in NuPAGE LDS Sample Buffer (Invitrogen, #NP0007) containing 1% (v/v) b-mercaptoethanol. Samples were loaded onto NuPAGE 4%-12% Bis-Tris gels (Invitrogen, #NP0335) and run with MES SDS running buffer (Invitrogen, #NP0002) at 100 V for 2 hours. After separation by SDS-PAGE, proteins were transferred to nitrocellulose membranes using a wet transfer system (transfer buffer: 25 mM Tris, 192 mM glycine, 20% methanol) for 1 hour at 100 V. After transfer, membranes were blocked in 5% milk in tris-buffered saline with 1% (v/v) Tween-20 (TBS-T) for 1 hour at room temperature. Membranes were then incubated with their respective primary antibodies diluted into blocking solution overnight at 4 C (see Table S1 for antibody sources and concentrations). After 3 washes in TBS-T, membranes were probed with HRP-conjugated secondary antibodies diluted into blocking solution (1:5000, Jackson ImmunoResearch Laboratories, see Table S1 for complete list) for 1 hour at room temperature. Blots were washed 3 times in TBS-T and developed with a chemiluminescence system as per manufacturer's instructions (Pierce ECL, ThermoFisher, #32106). Blots were imaged (ChemiDoc XRS, Bio-Rad; paired with Image Lab 5.0, Bio-rad) and band densitometry was measured with ImageJ v.2.0.0 (NIH). For quantification, specific protein levels were determined by normalizing to GAPDH loading control densitometry results. Gabra1-2 protein levels were normalized to WT control (100%). 5 independent experiments were performed for all western blotting experiments. Unpaired t tests with Welch's correction were performed on GraphPad Prism v.7.01 to compare mean values between WT and Gabra1-2, with values below *p < 0.05 considered significant. Graphs were plotted as mean ± standard error of the mean (SEM).
Biotinylation of cell surface proteins 8-12-week-old male mice of all genotypes (WT and Gabra1-2 homozygous for a1; pHa2 and pHa2/Gabra1-2 homozygous for a2) were anaesthetized with isofluorane and their brains were rapidly removed. 350 mm-thick coronal hippocampal slices were prepared and sectioned on a vibratome (Leica VT1000S) in ice-cold cutting solution containing 87 mM NaCl, 2.5 mM KCl, 0.5 mM CaCl 2 , 25 mM, NaHCO 3 , 1.25 mM NaH 2 PO 4 , 7 mM MgCl 2 , 50 mM sucrose, and 25 mM glucose. After sectioning, slices were allowed a 1-hour recovery period in 32 C artificial cerebrospinal fluid (aCSF) containing 126 mM NaCl, 26 mM NaHCO 3 , 2.5 mM KCl, 2 mM MgCl 2 , 2 mM CaCl 2 , 1mM glutamine, 1.25 mM NaH 2 PO 4 , 1.5 mM sodium pyruvate, and 10 mM glucose. Following recovery, slices were incubated for 45 minutes in ice-cold, 1 mg/mL EZ-Link Sulfo-NHS-SS-biotin (ThermoFisher, #21328T) in aCSF. All solutions described above were oxygenated with 95% (v/v) O 2 /5% (v/v) CO 2 . After 3 rinses in ice-cold 100 mM glycine in aSCF to halt the biotin reaction and 2 washes in ice-cold plain aCSF, samples were mechanically homogenized with a 26G needle and lysed in the previously described lysis buffer. Lysis was carried out as described above. After adjusting for protein concentration measured by BCA assay, hippocampal lysates (500 mg) were incubated with 50 mL of Strepavidin Agarose beads (ThermoFisher, #20347) on a rotator at 4 C overnight, with a portion (50 mg) reserved for total protein analysis. The supernatant was removed, and beads were washed in lysis buffer 3 times. All samples were mixed with NuPAGE LDS Sample Buffer (Invitrogen, #NP0007)/1% (v/v) b-mercaptoethanol. Samples were then boiled for 10 minutes at 70 C. Bound proteins and total protein samples were subjected to SDS and immunoblotting (see Table S1 for antibody sources and concentrations), developed, and imaged as described above. Band densitometry was measured with ImageJ v.2.0.0 (NIH) and protein levels were determined by normalizing to GAPDH (total protein) and/or pan-cadherin (surface protein) loading controls. The ratio of surface protein:total protein was calculated, and Gabra1-2 values were normalized to WT or pHa2 control (100%). 5 independent experiments were performed for all biotinylation experiments. Unpaired t tests with Welch's correction were performed on GraphPad Prism v.7.10 to compare mean values between WT and Gabra1-2 or pHa2 and Gabra1-2/pHa2, with data below p < 0.05 considered significant. Graphs were plotted as mean ± SEM.
Co-Immunoprecipiation (coIP)
Forebrains (cortex and hippocampus) were rapidly removed from isofluorane-anaesthetized 8-12-week-old male and female WT and Gabra1-2 mice and collected in an ice-cold cryoprotectant buffer (225 mM mannitol, 75 mM sucrose, 30 mM Tris-HCl, pH 7.4). Tissue was mechanically homogenized using 14 strokes of a dounce homogenizer in homogenization buffer (225 mM mannitol, 75 mM sucrose, 0.5% (w/v) BSA, 0.5 mM EGTA, 30 mM Tris-HCl, pH 7.4) and subjected to the following sequential centrifugation, all at 4 C: two 5-minute spins at 800 x g to remove unbroken cells; two 10-minute spins at 10,000 x g to remove mitochondria; and two 20-minute spins at 25,000 x g to isolate plasma membrane (PM) fractions. PM fractions were re-suspended and lysed in a lysis buffer containing 150 mM NaCl, 10 mM Tris, 0.5% Triton-X, and protease and phosphatase inhibitor cocktails, as above. These PM lysates (5000 mg protein) were incubated with 150 mL Protein A Dynabeads (ThermoFisher, #10001D) cross-linked to 15 mg of N-terminal a1 antibody (Abcam, #ab33299) overnight at 4 C. Supernatant was removed, and beads were washed 3 times in PBS with 0.05% (v/v) Tween. All samples were eluted in SDS-PAGE sample buffer. Immunoprecipitation samples were first boiled at 55 C for 10 minutes to remove protein complexes from the beads, and then both total lysate and immunoprecipitation samples were boiled at 95 C for 5 minutes. Samples were run through SDS-PAGE and western blotting for the appropriate proteins and developed and imaged as detailed above (see Table S1 for antibody sources and concentrations). For quantification using ImageJ v.2.0.0 (NIH), relative immunoprecipitation levels were determined by first normalizing to a1 densitometry results to account for differences in the amount of a1 present in WT versus Gabra1-2 samples. Gabra1-2 protein levels were then normalized to WT control (100%). 4 independent experiments were performed for the coIP experiments. Unpaired t tests with Welch's correction were performed on GraphPad Prism v.7.10 to compare mean values between WT and Gabra1-2, with data below p < 0.05 considered significant. Graphs were plotted as mean ± SEM.
Electrophysiology
Brain slices were prepared from 4-6-week-old WT and Gabra1-2 male, isofluorane-anaethetized mice. 300 mm sections were cut in ice-cold, oxygentated saline (92 mM NMDG, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 30 mM NaHCO 3 , 20 mM HEPES, 25 mM glucose, 2 mM thiourea, 5 mM Na-ascorbate, 3 mM Na-pyruvate, 0.5 mM CaCl 2 , 10 mM MgSO 4 ) using a vibratome (VT1000S, Leica), then incubated at 32 C for 10 minutes in holding aSCF (92 mM NaCl, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 30 mM NaHCO 3 , 20 mM HEPES, 25 mM glucose, 2 mM thiourea, 5 mM Na-ascorbate, 3 mM Na-pyruvate, 2 mM CaCl 2 , 2 mM MgSO 4 ). Brain slices were then transferred to the recording chamber and were continually perfused with normal aCSF (126 mM NaCl, 2.5 mM KCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 26 mM NaHCO 3 , 1.25 mM NaH 2 PO 4 , 10 mM glucose, 1.5 mM Na-pyruvate, 1 mM glutamine, 3 mM kynurenic acid, 0.005 M GABA) at 32 C. All solutions were bubbled with 95% (v/v) O 2 /5% (v/v) CO 2 . Patch pipettes (5-7 MU) were pulled from borosilicate glass (World Precision Instruments) and filled with intracellular solution (140 mM CsCl, 1 mM MgCl 2 , 0.1 mM EGTA, 10 mM HEPES, 2 mM Mg-ATP, 4 mM NaCl, 0.3 mM Na-GTP, pH to 7.2 with CsOH). To examine mini inhibitory postsynaptic currents (mIPSCs), tetrodotoxin (TTX; 0.5 mM) was added to the aCSF. A 5-minute stabilization period was allowed after obtaining the wholecell recording conformation (holding potential of À60 mV) in the hippocampal CA1. Subsequently, currents were recorded using an Axopatch 200B amplifier (Molecular Devices), low-pass filtered at 2 kHz, digitized at 20 kHz (Digidata 1440A; Molecular Devices), and stored for offline analysis. Series resistance and whole-cell capacitance were continually monitored and compensated for throughout the course of the experiment. Recordings were eliminated from data analysis if series resistance increased by > 20%. mIPSCs were analyzed using mini-analysis software v.5.6.4 (Synaptosoft). Minimum threshold detection was set to 3x the value of baseline noise signal. To assess mIPSC kinetics, the recording trace was visually inspected and only events with a stable baseline, sharp rising phase, and single peak were used to negate artifacts from event summation. Only recordings with a minimum of 200 events fitting these criteria were analyzed. mIPSC amplitude and frequency from each experimental condition were pooled and expressed as mean ± SEM. To measure mIPSC decay, we averaged 100 consecutive events, fit the decay to a double exponential, and took the weight decay constant (s). Statistical analysis for mean mIPSC kinetics was performed using a Mann-Whitney test, where p < 0.05 is considered significant. To display the distribution of mIPSC amplitudes, data was fitted with a Gaussian function:
Where A is the amplitude, m is the Gaussian mean amplitude current, s the Gaussian standard deviation, and C is the constant for each component i. For tonic current measurements in the CA1, once the response reached a plateau level an all-points histogram was plotted for a 10 s period before and during 100 mM picrotoxin application. Recordings with unstable baselines were discarded. Fitting the histogram with a Gaussian distribution gave the mean baseline current amplitude. The difference between the amplitudes before and during picrotoxin application was considered to be the tonic current. The negative section of the all-points histogram which in KA potency between cohorts. Results were analyzed with GraphPad Prism v.7.10 using either unpaired t tests or unpaired t tests with Welch's correction, where appropriate, to compare mean values between WT and Gabra1-2. Graphs were plotted as the mean ± SEM. Mortality data was plotted as a survival curve and analyzed with a log-rank (Mantel-Cox) test. Data below p < 0.05 was considered significant.
Survival assessments
Assessment of postnatal survival comparing Gabra2-1 heterozygotes and Gabra1-2/Gabra2-1 heterozygotes was performed. Litters were observed by the investigator once per day until weaning at postnatal day 21 (PND21) to check for pup death. After weaning, offspring were observed once per day to check for mortality until PND40. At least 20 pups per condition were assessed. Results were plotted with GraphPad Prism v.7.10 as the percent of animals alive from PND0-PND40.
QUANTIFICATION AND STATISTICAL ANALYSIS
All programs used for quantification and statistical analysis are outlined in the Method Details section. Statistical analyses are described in the corresponding figure legends and also in the Method Details section.
